Plan debates typically return to scheduling and bans. India and the United States both of those deal with versions of a similar problem: no matter if to impose broader, class-large controls in excess of fentanyl analogs and their precursors, or to help keep compound-by-substance scheduling which can lag powering traffickers’ innovation.India’s